Larry Dillaha, Chief Executive Officer of CavtheRx, was appointed interim President and Chief Executive Officer of the Company.
Prior to becoming CEO of CavtheRx, Dr. Dillaha was Chief Operating Officer and Chief Medical Officer of New Haven Pharmaceuticals, a specialty pharmaceutical company.
Dr. Dillaha also served as Chief Medical Officer of Insys Therapeutics, Sciele Pharma and as Medical Director of Sanofi-Sythelabo.
He received an M.D. degree from the University of Tennessee, Memphis. ■
LATEST MOVES FROM Texas
- Anadarko Petroleum appoints Danny Brown to SVP
- ConocoPhillips appoints Caroline Maury Devine to board
- Pier 1 Imports appoints Darla D. Ramirez as interim CFO
- Tuesday Morning appoints James T. Corcoran as director
- Reddy Ice appoints Deborah Conklin as CEO
More inside POST